Talk Presenting Companies (Theatre B) track
Metabolic Diseases: Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Mon, Nov 9, 2026 · 9:00–9:15 AM CET Koelnmesse
About this session
Founded in 2014, Innogen is a science-driven biopharmaceutical company dedicated to the research and development of innovative and affordable medicines for metabolic disease patients. Innogen's pipelines with indications in metabolic diseases including diabetes, obesity, MASH. are all independently developed and have global rights. Innogen has laid out global research and development and market sales. The company's first pipeline product, Efsubaglutide Alfa, was approved by the NMPA in January, 2025.
Speaker
-
Founder & CEO · Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Speaker